Analysts expect Biomerica Inc to report revenue of 2.27 M for Q4 21, against a range of 2.16 M to 2.38 M. The most recent reported quarter, Q3 24, came in at 1.12 M.
| Metric | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.60 M | - | 1.64 M | 1.48 M | 1.11 M | - | 1.64 M | 1.12 M | - | - | - | - | - |
| High Estimate | 3.05 M | 2.38 M | 3.00 M | 3.07 M | 3.03 M | 3.14 M | - | - | 1.96 M | 1.46 M | 1.28 M | 439,149.66 | 2.02 M |
| Low Estimate | 2.56 M | 2.16 M | 2.65 M | 2.80 M | 2.80 M | 2.85 M | - | - | 1.62 M | 1.29 M | 1.21 M | 413,041.10 | 1.71 M |
| Consensus Estimate | 2.80 M | 2.27 M | 2.83 M | 2.93 M | 2.91 M | 2.99 M | - | - | 1.79 M | 1.38 M | 1.25 M | 426,095.38 | 1.86 M |
Analysts expect Biomerica Inc to report earnings per share of -0.94 for Q4 21, against a range of -0.98 to -0.90. The most recent reported quarter, Q3 24, came in at -0.48.
| Metric | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.08 | - | -1.28 | -0.96 | -0.96 | - | -0.48 | -0.48 | - | - | - | - | - |
| High Estimate | -0.73 | -0.90 | -0.14 | 0.00 | 0.19 | 0.36 | - | - | -0.27 | -0.52 | -0.28 | -0.90 | 0.34 |
| Low Estimate | -0.83 | -0.98 | -0.16 | 0.00 | 0.15 | 0.30 | - | - | -0.31 | -0.60 | -0.30 | -1.02 | 0.32 |
| Consensus Estimate | -0.78 | -0.94 | -0.15 | 0.00 | 0.17 | 0.33 | - | - | -0.29 | -0.56 | -0.29 | -0.96 | 0.33 |